Literature DB >> 10073281

Postural hypotension: causes, clinical features, investigation, and management.

C J Mathias1, J R Kimber.   

Abstract

Postural hypotension may result from various neurogenic and non-neurogenic causes. It may be a key feature of certain disorders, such as the primary chronic autonomic failure syndromes; it can complicate a variety of diseases, such as diabetes mellitus; and its prevalence increases with advancing age. When symptomatic, it may result in loss of consciousness and thus cause injury. Postural hypotension can be suspected from the patient's history and is readily documented in the clinic by measuring lying and standing blood pressure. The diagnosis ideally should be confirmed in the laboratory with additional tests to determine the cause and evaluate the functional deficit, so as to aid treatment. Treatment of the causative disorder is often curative when there are non-neurogenic causes. A combination of nonpharmacological and pharmacological measures is needed in the management of neurogenic postural hypotension.

Entities:  

Mesh:

Year:  1999        PMID: 10073281     DOI: 10.1146/annurev.med.50.1.317

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  15 in total

1.  Blood pressure and dementia - a comprehensive review.

Authors:  Sean P Kennelly; Brian A Lawlor; Rose Anne Kenny
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  Application of the Sit-Up Test for orthostatic hypotension in individuals with stroke.

Authors:  Ada Tang; Janice J Eng; Andrei Krassioukov
Journal:  Auton Neurosci       Date:  2012-02-29       Impact factor: 3.145

3.  L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.

Authors:  C J Mathias; J M Senard; S Braune; L Watson; A Aragishi; J E Keeling; M D Taylor
Journal:  Clin Auton Res       Date:  2001-08       Impact factor: 4.435

Review 4.  Management of multiple system atrophy: state of the art.

Authors:  C Colosimo; D Tiple; G K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

Review 5.  Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.

Authors:  Ahmed Elgebaly; Bassant Abdelazeim; Omar Mattar; Mohamed Gadelkarim; Rehab Salah; Ahmed Negida
Journal:  Clin Auton Res       Date:  2016-03-07       Impact factor: 4.435

6.  Mortality and prognosis in patients with neurogenic orthostatic hypotension.

Authors:  Simona Maule; Valeria Milazzo; Milena Maria Maule; Cristina Di Stefano; Alberto Milan; Franco Veglio
Journal:  Funct Neurol       Date:  2012 Apr-Jun

7.  [Prevalence of orthostatic hypotension and its risk factors in treated hypertensive black Africans].

Authors:  Soodougoua Baragou; Machiude Pio; Soulemane Pessinaba; Datouda Redah
Journal:  Pan Afr Med J       Date:  2012-01-21

8.  Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project).

Authors:  Artur Fedorowski; Lars Stavenow; Bo Hedblad; Göran Berglund; Peter M Nilsson; Olle Melander
Journal:  Eur Heart J       Date:  2009-08-20       Impact factor: 29.983

9.  Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease.

Authors:  Eva Stuebner; Ekawat Vichayanrat; David A Low; Christopher J Mathias; Stefan Isenmann; Carl-Albrecht Haensch
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

10.  Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.

Authors:  Horacio Kaufmann; Roy Freeman; Italo Biaggioni; Phillip Low; Simon Pedder; L Arthur Hewitt; Joe Mauney; Michael Feirtag; Christopher J Mathias
Journal:  Neurology       Date:  2014-06-18       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.